Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States Denosumab is widely used in the treatment of bone metastases ...
As the use of molecular biomarkers in brain tumor diagnosis has been further elucidated, challenges have arisen in how to predict the probability of survival via various signaling molecules 1. Over 70 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results